Tag: GLP-1 GIP agonist

Tirzepatide for Weight Loss: How Dual Incretin Therapy Works and What to Expect
Medications
Tirzepatide for Weight Loss: How Dual Incretin Therapy Works and What to Expect

Tirzepatide (Zepbound) is a dual incretin therapy that targets GLP-1 and GIP receptors for significant weight loss. Learn how it works, what to expect, side effects, cost, and real results from clinical trials and patient experiences.

Read More